{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:45:36Z","timestamp":1769748336527,"version":"3.49.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The complexity of the cancer cachexia phenotype has undoubtedly hindered researchers\u2019 understanding of this devastating syndrome. The presence and magnitude of host\u2013tumour interactions are rarely considered during clinical decision-making within the current staging paradigm. Furthermore, treatment options for those patients who are identified as suffering from cancer cachexia remain extremely limited.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Previous attempts to characterise cachexia have largely focussed on individual surrogate disease markers, often studied across a limited timeframe. While the adverse prognostic value of clinical and biochemical features is evident, the relationships between these are less clear. Investigation of patients with earlier-stage disease could allow researchers to identify markers of cachexia that precede the refractory stage of the wasting process. Appreciation of the cachectic phenotype within \u2018curative\u2019 populations may aid our understanding of the syndrome\u2019s genesis and provide potential routes for prevention, rather than treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Holistic, longitudinal characterisation of cancer cachexia, across all at-risk and affected populations, is of vital importance for future research in the field. This paper presents the protocol for an observational study aiming to create a robust and holistic characterisation of surgical patients with, or at risk of, cancer cachexia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/spc.0000000000000660","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T15:04:47Z","timestamp":1688137487000},"page":"172-176","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Longitudinal characterisation of cachexia in patients undergoing surgical resection for cancer"],"prefix":"10.1097","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6181-7020","authenticated-orcid":false,"given":"Leo R.","family":"Brown","sequence":"first","affiliation":[{"name":"Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry J.A.","family":"Laird","sequence":"additional","affiliation":[{"name":"St Columba\u2019s Hospice"},{"name":"Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, Scotland, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Wigmore","sequence":"additional","affiliation":[{"name":"Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.E.","family":"Skipworth","sequence":"additional","affiliation":[{"name":"Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"key":"R1-20250525","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13539-014-0164-8","article-title":"Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014","volume":"5","author":"von Haehling","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R2-20250525","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primer"},{"key":"R3-20250525","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jcsm.12307","article-title":"Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer: distinct cachexia phenotypes and survival in PDAC","volume":"9","author":"Kays","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R4-20250525","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ejca.2008.02.033","article-title":"Cancer cachexia: developing multimodal therapy for a multidimensional problem","volume":"44","author":"Fearon","year":"2008","journal-title":"Eur J Cancer"},{"key":"R5-20250525","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"R6-20250525","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/jcsm.12083","article-title":"Request for regulatory guidance for cancer cachexia intervention trials: editorial","volume":"6","author":"Fearon","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R7-20250525","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/SPC.0000000000000381","article-title":"The relationship between muscle mass and function in cancer cachexia: smoke and mirrors\u202f?","volume":"12","author":"Ramage","year":"2018","journal-title":"Curr Opin Support Palliat Care"},{"key":"R8-20250525","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"},{"key":"R9-20250525","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.clnu.2016.12.016","article-title":"The relationship between muscle protein content and CT-derived muscle radio-density in patients with upper GI cancer","volume":"37","author":"Ramage","year":"2018","journal-title":"Clin Nutr"},{"key":"R10-20250525","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41416-022-01826-2","article-title":"Cancer cachexia: a nutritional or a systemic inflammatory syndrome?","volume":"127","author":"McGovern","year":"2022","journal-title":"Br J Cancer"},{"key":"R11-20250525","doi-asserted-by":"crossref","first-page":"16717","DOI":"10.1038\/s41598-017-16955-5","article-title":"The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta-analysis","volume":"7","author":"Dolan","year":"2017","journal-title":"Sci Rep"},{"key":"R12-20250525","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.critrevonc.2017.06.002","article-title":"The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta -analysis","volume":"116","author":"Dolan","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"R13-20250525","doi-asserted-by":"crossref","first-page":"103222","DOI":"10.1016\/j.critrevonc.2021.103222","article-title":"Relationship between cytokines and symptoms in people with incurable cancer: a systematic review","volume":"159","author":"Patton","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"R16-20250525","article-title":"Comprehensive validation of automated whole body skeletal muscle, adipose tissue, and bone segmentation from 3D CT images for body composition analysis: towards extended body composition","author":"Ma","year":"2021","journal-title":"arXiv"},{"key":"R17-20250525","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"R18-20250525","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/JCO.1984.2.3.187","article-title":"Karnofsky performance status revisited: reliability, validity, and guidelines","volume":"2","author":"Schag","year":"1984","journal-title":"J Clin Oncol"},{"key":"R19-20250525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2017-017928","article-title":"Influence of frailty in older patients undergoing emergency laparotomy: a UK-based observational study","volume":"7","author":"Parmar","year":"2017","journal-title":"BMJ Open"},{"key":"R20-20250525","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The Timed \u201cUp & Go\u201d: a test of basic functional mobility for frail elderly persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"R21-20250525","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"R22-20250525","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12913-016-1950-0","article-title":"Mobility as a predictor of all-cause mortality in older men and women: 11.8 year follow-up in the Troms\u00f8 study","volume":"17","author":"Bergland","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"R23-20250525","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1200\/CCI.20.00117","article-title":"Feasibility of fitness tracker usage to assess activity level and toxicities in patients with colorectal cancer","volume":"5","author":"Ward","year":"2021","journal-title":"JCO Clin Cancer Inform"},{"key":"R24-20250525","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41416-022-02099-5","article-title":"Lactate dehydrogenase: relationship with the diagnostic GLIM criterion for cachexia in patients with advanced cancer","volume":"128","author":"McGovern","year":"2023","journal-title":"Br J Cancer"},{"key":"R25-20250525","first-page":"165","article-title":"Identification of diagnostic upper gastrointestinal cancer tissue type-specific urinary biomarkers","volume":"10","author":"Husi","year":"2019","journal-title":"Biomed Rep"},{"key":"R26-20250525","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.7150\/jca.16244","article-title":"Role of urinary biomarkers in the diagnosis of adenoma and colorectal cancer: a systematic review and meta-analysis","volume":"7","author":"Altobelli","year":"2016","journal-title":"J Cancer"},{"key":"R27-20250525","first-page":"547","article-title":"Urinary diagnostic proteomic markers for dynapenia in cancer patients","volume":"8","author":"Husi","year":"2018","journal-title":"Biomed Rep"},{"key":"R28-20250525","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jcsm.12005","article-title":"Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients: evaluating potential biomarkers of cachexia and survival","volume":"6","author":"Stephens","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R29-20250525","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/jcsm.12568","article-title":"Adipose depot gene expression and intelectin\u20101 in the metabolic response to cancer and cachexia","volume":"11","author":"Miller","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T18:03:56Z","timestamp":1748196236000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SPC.0000000000000660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0000000000000660","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,30]]}}}